1. Home
  2. BWB vs ENGN Comparison

BWB vs ENGN Comparison

Compare BWB & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWB

Bridgewater Bancshares Inc.

HOLD

Current Price

$17.49

Market Cap

515.6M

Sector

Finance

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.03

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWB
ENGN
Founded
2005
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
515.6M
605.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BWB
ENGN
Price
$17.49
$9.03
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$20.33
$22.71
AVG Volume (30 Days)
87.6K
245.0K
Earning Date
01-28-2026
12-22-2025
Dividend Yield
N/A
N/A
EPS Growth
25.72
N/A
EPS
1.32
N/A
Revenue
$127,243,000.00
N/A
Revenue This Year
$35.67
N/A
Revenue Next Year
$14.88
N/A
P/E Ratio
$13.28
N/A
Revenue Growth
20.40
N/A
52 Week Low
$11.93
$2.65
52 Week High
$19.11
$11.14

Technical Indicators

Market Signals
Indicator
BWB
ENGN
Relative Strength Index (RSI) 41.95 58.22
Support Level $17.90 $7.57
Resistance Level $19.11 $9.81
Average True Range (ATR) 0.38 0.72
MACD -0.15 0.04
Stochastic Oscillator 2.39 60.47

Price Performance

Historical Comparison
BWB
ENGN

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: